Westwood Holdings Group Inc. Sells 55,508 Shares of Prestige Consumer Healthcare Inc. (NYSE:PBH)

Westwood Holdings Group Inc. cut its stake in Prestige Consumer Healthcare Inc. (NYSE:PBH - Free Report) by 6.5% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 804,480 shares of the company's stock after selling 55,508 shares during the period. Westwood Holdings Group Inc. owned approximately 1.63% of Prestige Consumer Healthcare worth $62,822,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in PBH. Franklin Resources Inc. grew its stake in shares of Prestige Consumer Healthcare by 0.7% in the fourth quarter. Franklin Resources Inc. now owns 21,735 shares of the company's stock valued at $1,697,000 after acquiring an additional 150 shares in the last quarter. CIBC Private Wealth Group LLC lifted its holdings in shares of Prestige Consumer Healthcare by 48.9% in the fourth quarter. CIBC Private Wealth Group LLC now owns 463 shares of the company's stock worth $34,000 after acquiring an additional 152 shares during the last quarter. QRG Capital Management Inc. lifted its holdings in shares of Prestige Consumer Healthcare by 3.3% in the fourth quarter. QRG Capital Management Inc. now owns 5,496 shares of the company's stock worth $429,000 after acquiring an additional 176 shares during the last quarter. O Shaughnessy Asset Management LLC raised its holdings in Prestige Consumer Healthcare by 3.0% in the 4th quarter. O Shaughnessy Asset Management LLC now owns 7,026 shares of the company's stock valued at $549,000 after buying an additional 207 shares during the last quarter. Finally, Summit Investment Advisors Inc. raised its holdings in Prestige Consumer Healthcare by 4.2% in the 4th quarter. Summit Investment Advisors Inc. now owns 5,182 shares of the company's stock valued at $405,000 after buying an additional 211 shares during the last quarter. 99.95% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Several analysts have recently commented on PBH shares. DA Davidson raised their price objective on shares of Prestige Consumer Healthcare from $95.00 to $104.00 and gave the stock a "buy" rating in a research report on Friday, February 7th. Oppenheimer raised their price objective on shares of Prestige Consumer Healthcare from $87.00 to $93.00 and gave the stock an "outperform" rating in a research report on Thursday, February 13th. Wall Street Zen raised shares of Prestige Consumer Healthcare from a "hold" rating to a "buy" rating in a research report on Saturday, May 17th. Canaccord Genuity Group raised their price objective on shares of Prestige Consumer Healthcare from $93.00 to $100.00 and gave the stock a "buy" rating in a research report on Friday, February 7th. Finally, Royal Bank of Canada raised shares of Prestige Consumer Healthcare to a "hold" rating in a research report on Thursday, May 8th. Three investment analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. Based on data from MarketBeat, the company currently has an average rating of "Moderate Buy" and a consensus price target of $93.33.

Insider Transactions at Prestige Consumer Healthcare

In other news, SVP Mary Beth Fritz sold 1,678 shares of Prestige Consumer Healthcare stock in a transaction on Monday, March 10th. The stock was sold at an average price of $90.00, for a total transaction of $151,020.00. Following the sale, the senior vice president now directly owns 17,157 shares in the company, valued at $1,544,130. The trade was a 8.91% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Company insiders own 1.60% of the company's stock.

Prestige Consumer Healthcare Stock Up 0.6%

NYSE:PBH traded up $0.47 during trading hours on Thursday, hitting $84.89. 381,921 shares of the company traded hands, compared to its average volume of 297,202. The company has a quick ratio of 2.20, a current ratio of 3.68 and a debt-to-equity ratio of 0.56. The firm's 50-day simple moving average is $83.48 and its 200-day simple moving average is $82.10. Prestige Consumer Healthcare Inc. has a one year low of $62.35 and a one year high of $92.24. The company has a market cap of $4.19 billion, a PE ratio of 19.88, a PEG ratio of 2.69 and a beta of 0.44.

Prestige Consumer Healthcare (NYSE:PBH - Get Free Report) last issued its quarterly earnings data on Thursday, May 8th. The company reported $1.32 earnings per share for the quarter, beating the consensus estimate of $1.30 by $0.02. The business had revenue of $296.52 million for the quarter, compared to analysts' expectations of $289.36 million. Prestige Consumer Healthcare had a return on equity of 12.36% and a net margin of 19.13%. The business's revenue was up 7.0% on a year-over-year basis. During the same period last year, the business earned $1.02 EPS. Equities analysts predict that Prestige Consumer Healthcare Inc. will post 4.5 earnings per share for the current year.

Prestige Consumer Healthcare Profile

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.